• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新一代针对细胞黏附性前列腺特异性膜抗原的单克隆抗体和重组抗体,用于前列腺癌的诊断和治疗靶向。

A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.

作者信息

Elsässer-Beile Ursula, Wolf Philipp, Gierschner Dorothee, Bühler Patrick, Schultze-Seemann Wolfgang, Wetterauer Ulrich

机构信息

Department of Urology, Experimental Urology, University of Freiburg, Freiburg, Germany.

出版信息

Prostate. 2006 Sep 15;66(13):1359-70. doi: 10.1002/pros.20367.

DOI:10.1002/pros.20367
PMID:16894535
Abstract

BACKGROUND

Prostate-specific membrane antigen (PSMA) is an excellent candidate for targeting prostate cancer by virtue of its restricted expression on prostatic epithelial cells and its upregulation on prostatic carcinoma cells. PSMA is expressed on the cell surface displaying a specific three-dimensional structure. Therefore, only antibodies with a high cell binding activity will have an important impact on antibody-based imaging and therapy.

METHODS

Monoclonal antibodies (mAbs) and single chain antibody fragments (scFvs) were prepared from spleen cells of mice that had been immunized either with purified PSMA or a cell lysate of prostate cancer LNCaP cells containing native PSMA. mAbs and scFvs were screened for reactivity with purified PSMA and binding to PSMA-expressing LNCaP cells.

RESULTS

From mice immunized with purified PSMA, we obtained three mAbs (K7, K12, D20) and four scFvs (G0, G1, G2, G4), which were highly reactive with the isolated antigen, but showed weak or no reaction with viable LNCaP cells. From mice immunized with unpurified LNCaP lysate, we obtained three mAbs (3/E7, 3/F11, 3/A12), and one scFv (A5), which were reactive with purified PSMA, also showing a strong and specific binding to viable LNCaP cells and PSMA-transfected cells.

CONCLUSIONS

Our results suggest that only the mAbs and scFvs, that were elicited with unpurified LNCaP lysate and not with purified PSMA will be useful agents for diagnostic imaging and therapeutic applications of prostate cancer.

摘要

背景

前列腺特异性膜抗原(PSMA)因其在前列腺上皮细胞上的限制性表达以及在前列腺癌细胞上的上调,是靶向前列腺癌的极佳候选物。PSMA在细胞表面表达,呈现特定的三维结构。因此,只有具有高细胞结合活性的抗体才会对基于抗体的成像和治疗产生重要影响。

方法

从用纯化的PSMA或含有天然PSMA的前列腺癌LNCaP细胞裂解物免疫的小鼠脾细胞中制备单克隆抗体(mAb)和单链抗体片段(scFv)。筛选mAb和scFv与纯化的PSMA的反应性以及与表达PSMA的LNCaP细胞的结合。

结果

在用纯化的PSMA免疫的小鼠中,我们获得了三种mAb(K7、K12、D20)和四种scFv(G0、G1、G2、G4),它们与分离的抗原高度反应,但与活的LNCaP细胞反应较弱或无反应。在用未纯化的LNCaP裂解物免疫的小鼠中,我们获得了三种mAb(3/E7、3/F11、3/A12)和一种scFv(A5),它们与纯化的PSMA反应,也显示出与活的LNCaP细胞和PSMA转染细胞的强特异性结合。

结论

我们的结果表明,只有用未纯化的LNCaP裂解物而非纯化的PSMA诱导产生的mAb和scFv才是前列腺癌诊断成像和治疗应用的有用试剂。

相似文献

1
A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.新一代针对细胞黏附性前列腺特异性膜抗原的单克隆抗体和重组抗体,用于前列腺癌的诊断和治疗靶向。
Prostate. 2006 Sep 15;66(13):1359-70. doi: 10.1002/pros.20367.
2
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.三种针对不同 PSMA 表位的构象抗体是前列腺癌有前途的诊断和治疗工具。
Prostate. 2010 Apr 1;70(5):562-9. doi: 10.1002/pros.21090.
3
In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.前列腺特异性膜抗原细胞外结构域特异性放射性标记单克隆抗体的体外特性研究
Cancer Res. 2000 Sep 15;60(18):5237-43.
4
Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.一种针对人及小鼠前列腺特异性膜抗原的免疫毒素对小鼠的抗肿瘤作用及无副作用情况
Prostate. 2004 Sep 15;61(1):1-11. doi: 10.1002/pros.20074.
5
PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.前列腺特异性膜抗原(PSMA)特异性单链抗体介导的Notch1靶向敲低抑制人前列腺癌细胞增殖和肿瘤生长。
Cancer Lett. 2013 Sep 28;338(2):282-91. doi: 10.1016/j.canlet.2013.05.035. Epub 2013 Jun 7.
6
High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA.采用三种不同的针对天然细胞黏附 PSMA 的 64Cu 标记抗体对前列腺癌异种移植进行高分辨率动物 PET 成像。
Prostate. 2010 Sep 15;70(13):1413-21. doi: 10.1002/pros.21176.
7
Novel Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (PSMA) as Research and Theranostic Tools.新型单克隆抗体识别人类前列腺特异性膜抗原(PSMA)作为研究和诊疗工具。
Prostate. 2017 May;77(7):749-764. doi: 10.1002/pros.23311. Epub 2017 Mar 1.
8
Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.用111In标记的D2B IgG、F(ab')2和Fab片段靶向裸鼠中表达前列腺特异性膜抗原(PSMA)的异种移植瘤的人前列腺癌。
Contrast Media Mol Imaging. 2015 Jan-Feb;10(1):28-36. doi: 10.1002/cmmi.1596. Epub 2014 Apr 25.
9
Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor.通过基于纳米抗体的嵌合抗原受体靶向前列腺癌细胞上前列腺特异性膜抗原的工程化人 Jurkat 细胞。
Iran Biomed J. 2020 Mar;24(2):81-8. doi: 10.29252/ibj.24.2.81. Epub 2019 Oct 23.
10
A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer.一种新型抗前列腺特异性膜抗原(PSMA)的人源单链抗体片段(scFv)有潜力用作前列腺癌的诊断工具。
Oncotarget. 2016 Sep 13;7(37):59471-59481. doi: 10.18632/oncotarget.10697.

引用本文的文献

1
A new silicon phthalocyanine dye induces pyroptosis in prostate cancer cells during photoimmunotherapy.一种新型硅酞菁染料在光免疫治疗过程中可诱导前列腺癌细胞发生焦亡。
Bioact Mater. 2024 Aug 16;41:537-552. doi: 10.1016/j.bioactmat.2024.07.025. eCollection 2024 Nov.
2
Enhanced cytotoxicity of a Exotoxin A based immunotoxin against prostate cancer by addition of the endosomal escape enhancer SO1861.通过添加内体逃逸增强剂SO1861增强基于外毒素A的免疫毒素对前列腺癌的细胞毒性。
Front Pharmacol. 2023 Jul 6;14:1211824. doi: 10.3389/fphar.2023.1211824. eCollection 2023.
3
Targeted Toxins for the Treatment of Prostate Cancer.
用于治疗前列腺癌的靶向毒素
Biomedicines. 2021 Aug 9;9(8):986. doi: 10.3390/biomedicines9080986.
4
Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer.比较用于前列腺癌诊断的临床转化研究中的前列腺特异性膜抗原配体。
Cancer Rep (Hoboken). 2019 Aug;2(4):e1169. doi: 10.1002/cnr2.1169. Epub 2019 Apr 2.
5
ImmunoPET: Concept, Design, and Applications.免疫正电子发射断层扫描:概念、设计与应用。
Chem Rev. 2020 Apr 22;120(8):3787-3851. doi: 10.1021/acs.chemrev.9b00738. Epub 2020 Mar 23.
6
Radiochemistry and Preclinical PET Imaging of Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen.靶向前列腺特异性膜抗原的镓去铁胺放射性示踪剂的放射化学与临床前正电子发射断层显像
Mol Imaging. 2017 Jan-Dec;16:1536012117737010. doi: 10.1177/1536012117737010.
7
Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.用于前列腺癌诊断和免疫治疗的新型靶向前列腺干细胞抗原(PSCA)的单链抗体片段(scFv)融合蛋白
J Cancer Res Clin Oncol. 2017 Oct;143(10):2025-2038. doi: 10.1007/s00432-017-2472-9. Epub 2017 Jun 30.
8
Metal-Based PSMA Radioligands.基于金属的前列腺特异性膜抗原放射性配体
Molecules. 2017 Mar 24;22(4):523. doi: 10.3390/molecules22040523.
9
In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer.重组抗前列腺特异性膜抗原免疫毒素联合多西他赛对前列腺癌的体内外作用
Oncotarget. 2016 Apr 19;7(16):22531-42. doi: 10.18632/oncotarget.8001.
10
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.(R)-NODAGA-PSMA:用于PSMA阳性肿瘤放射性金属标记和核成像的多功能前体。
PLoS One. 2015 Dec 23;10(12):e0145755. doi: 10.1371/journal.pone.0145755. eCollection 2015.